The University of Southampton
University of Southampton Institutional Repository

Time to full publication of studies of anti-cancer medicines for breast cancer, and the potential for publication bias: a short systematic review

Takeda, A., Loveman, E., Harris, P., Hartwell, D. and Welch, K. (2008) Time to full publication of studies of anti-cancer medicines for breast cancer, and the potential for publication bias: a short systematic review Health Technology Assessment, 12, (32), pp. 1-68. (doi:10.3310/hta12320). (PMID:18831948).

Record type: Article


Objectives: To identify the expected delay between publication of conference abstracts and full publication of results from trials of new anti-cancer agents for breast cancer and to identify whether there are any apparent biases in publication and reporting.

Data sources: Major electronic databases were searched to identify randomised controlled trials (RCTs) of the selected interventions for the treatment of breast cancer.

Review methods: A systematic review was conducted according to standard methods. Data were extracted from the included studies using a predesigned and piloted data extraction template.

Results: Six anti-cancer treatments for breast cancer were included in the review: docetaxel, paclitaxel, trastuzumab, gemcitabine, lapatinib and bevacizumab. The literature searches generated 1556 references, from which 71 publications were retrieved and screened for inclusion. Screening identified 41 publications of 18 RCTs with at least one arm of treatment meeting the inclusion criteria for the review. Of the 18 included RCTs, only four publications (from three RCTs) reported the same outcomes in both an abstract and a full publication. Time between the abstract and full publication was 5 months in two cases, 7 months in one case and 19 months in one case (overall mean delay = 9 months). Eleven trials were identified that have not currently published in a full publication the data presented in an abstract or conference proceeding. The duration between publication of the abstracts and the end of August 2007 varied from 3 months to 38 months (mean delay 16.5 months). The longest delays in publication were for trials investigating gemcitabine (38 months) or bevacizumab (33 months). Observational analysis of the published and unpublished trials did not indicate any particular biases in terms of whether positive results were more likely to be fully published than non-significant ones.

Conclusions: It was surprising that only three of the 18 relevant RCTs had one or more full papers that reported the same outcome measures (and stage of analysis) as an earlier conference abstract. However, a limitation of this review is the small number of studies included. With a larger sample size than that in the present report, investigation into the effect of publication delay on decision-making might be feasible. Future research should include extension of this work to other anticancer drugs and investigation into the reasons for lengthy delays to full publication noted for some trials.

PDF mon1232.pdf - Version of Record
Download (370kB)

More information

Published date: October 2008
Keywords: systematic review, breast cancer, chemotherapy


Local EPrints ID: 72887
ISSN: 1366-5278
PURE UUID: cfa52c92-0f48-4549-9a16-b0ccc80eba2a

Catalogue record

Date deposited: 24 Feb 2010
Last modified: 18 Jul 2017 23:52

Export record



Author: A. Takeda
Author: E. Loveman
Author: P. Harris
Author: D. Hartwell
Author: K. Welch

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton:

ePrints Soton supports OAI 2.0 with a base URL of

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.